The Three‐Dimensional Structure of the N‐Terminal Domain of Corticotropin‐Releasing Factor Receptors Sushi Domains and the B1 Family of G Protein–Coupled Receptors

The corticotropin‐releasing factor (CRF) receptors, CRF‐R1 and CRF‐R2, belong to the B1 subfamily of G protein–coupled Receptors (GPCRs), including receptors for secretin, growth hormone‐releasing hormone (GHRH), vasoactive intestinal peptide (VIP), pituitary adenylate cyclase‐activating polypeptide...

Full description

Saved in:
Bibliographic Details
Published inAnnals of the New York Academy of Sciences Vol. 1070; no. 1; pp. 105 - 119
Main Authors PERRIN, MARILYN H., GRACE, CHRISTY R. R., RIEK, ROLAND, VALE, WYLIE W.
Format Journal Article
LanguageEnglish
Published United States 01.07.2006
Subjects
Online AccessGet full text
ISSN0077-8923
1749-6632
DOI10.1196/annals.1317.065

Cover

Abstract The corticotropin‐releasing factor (CRF) receptors, CRF‐R1 and CRF‐R2, belong to the B1 subfamily of G protein–coupled Receptors (GPCRs), including receptors for secretin, growth hormone‐releasing hormone (GHRH), vasoactive intestinal peptide (VIP), pituitary adenylate cyclase‐activating polypeptide (PACAP), calcitonin, parathyroid hormone (PTH), glucagon, and glucagon‐like peptide‐1 (GLP‐1). The peptide ligand family comprises CRF, Ucn 1, 2, and 3. CRF plays the major role in integrating the response to stress. Additionally, the ligands exhibit many effects on muscle, pancreas, heart, and the GI, reproductive, and immune systems. CRF‐R1 has higher affinity for CRF than does CRF‐R2 while both receptors bind Ucn 1 equally. CRF‐R2 shows specificity for Ucns 2 and 3. A major binding domain of the CRFRs is the N terminus/first extracellular domain (ECD1). Soluble proteins corresponding to the ECD1s of each receptor bind CRF ligands with nanomolar affinities. Our three‐dimentional (3D) nuclear magnetic resonance (NMR) structure of a soluble protein corresponding to the ECD1 of CRF‐R2β ( 1 ) identified its structural fold as a Sushi domain/short consensus repeat (SCR), stabilized by three disulfide bridges, two tryptophan residues, and an internal salt bridge (Asp65–Arg101) . Disruption of the bridge by D65A mutation abrogates ligand recognition and results in loss of the well‐defined disulfide pattern and Sushi domain structure. NMR analysis of the ECD1 in complex with astressin identified key amino acids involved in ligand recognition. Mutation of some of these residues in the full‐length receptor reduces its affinity for CRF ligands. A structure‐based sequence comparison shows conservation of key amino acids in all the B1 subfamily receptors, suggesting a corresponding conservation of a Sushi domain structural fold of their ECD1s.
AbstractList The corticotropin‐releasing factor (CRF) receptors, CRF‐R1 and CRF‐R2, belong to the B1 subfamily of G protein–coupled Receptors (GPCRs), including receptors for secretin, growth hormone‐releasing hormone (GHRH), vasoactive intestinal peptide (VIP), pituitary adenylate cyclase‐activating polypeptide (PACAP), calcitonin, parathyroid hormone (PTH), glucagon, and glucagon‐like peptide‐1 (GLP‐1). The peptide ligand family comprises CRF, Ucn 1, 2, and 3. CRF plays the major role in integrating the response to stress. Additionally, the ligands exhibit many effects on muscle, pancreas, heart, and the GI, reproductive, and immune systems. CRF‐R1 has higher affinity for CRF than does CRF‐R2 while both receptors bind Ucn 1 equally. CRF‐R2 shows specificity for Ucns 2 and 3. A major binding domain of the CRFRs is the N terminus/first extracellular domain (ECD1). Soluble proteins corresponding to the ECD1s of each receptor bind CRF ligands with nanomolar affinities. Our three‐dimentional (3D) nuclear magnetic resonance (NMR) structure of a soluble protein corresponding to the ECD1 of CRF‐R2β ( 1 ) identified its structural fold as a Sushi domain/short consensus repeat (SCR), stabilized by three disulfide bridges, two tryptophan residues, and an internal salt bridge (Asp65–Arg101) . Disruption of the bridge by D65A mutation abrogates ligand recognition and results in loss of the well‐defined disulfide pattern and Sushi domain structure. NMR analysis of the ECD1 in complex with astressin identified key amino acids involved in ligand recognition. Mutation of some of these residues in the full‐length receptor reduces its affinity for CRF ligands. A structure‐based sequence comparison shows conservation of key amino acids in all the B1 subfamily receptors, suggesting a corresponding conservation of a Sushi domain structural fold of their ECD1s.
The corticotropin-releasing factor (CRF) receptors, CRF-R1 and CRF-R2, belong to the B1 subfamily of G protein-coupled Receptors (GPCRs), including receptors for secretin, growth hormone-releasing hormone (GHRH), vasoactive intestinal peptide (VIP), pituitary adenylate cyclase-activating polypeptide (PACAP), calcitonin, parathyroid hormone (PTH), glucagon, and glucagon-like peptide-1 (GLP-1). The peptide ligand family comprises CRF, Ucn 1, 2, and 3. CRF plays the major role in integrating the response to stress. Additionally, the ligands exhibit many effects on muscle, pancreas, heart, and the GI, reproductive, and immune systems. CRF-R1 has higher affinity for CRF than does CRF-R2 while both receptors bind Ucn 1 equally. CRF-R2 shows specificity for Ucns 2 and 3. A major binding domain of the CRFRs is the N terminus/first extracellular domain (ECD1). Soluble proteins corresponding to the ECD1s of each receptor bind CRF ligands with nanomolar affinities. Our three-dimentional (3D) nuclear magnetic resonance (NMR) structure of a soluble protein corresponding to the ECD1 of CRF-R2 beta (1) identified its structural fold as a Sushi domain/short consensus repeat (SCR), stabilized by three disulfide bridges, two tryptophan residues, and an internal salt bridge (Asp65-Arg101). Disruption of the bridge by D65A mutation abrogates ligand recognition and results in loss of the well-defined disulfide pattern and Sushi domain structure. NMR analysis of the ECD1 in complex with astressin identified key amino acids involved in ligand recognition. Mutation of some of these residues in the full-length receptor reduces its affinity for CRF ligands. A structure-based sequence comparison shows conservation of key amino acids in all the B1 subfamily receptors, suggesting a corresponding conservation of a Sushi domain structural fold of their ECD1s.
The corticotropin-releasing factor (CRF) receptors, CRF-R1 and CRF-R2, belong to the B1 subfamily of G protein-coupled Receptors (GPCRs), including receptors for secretin, growth hormone-releasing hormone (GHRH), vasoactive intestinal peptide (VIP), pituitary adenylate cyclase-activating polypeptide (PACAP), calcitonin, parathyroid hormone (PTH), glucagon, and glucagon-like peptide-1 (GLP-1). The peptide ligand family comprises CRF, Ucn 1, 2, and 3. CRF plays the major role in integrating the response to stress. Additionally, the ligands exhibit many effects on muscle, pancreas, heart, and the GI, reproductive, and immune systems. CRF-R1 has higher affinity for CRF than does CRF-R2 while both receptors bind Ucn 1 equally. CRF-R2 shows specificity for Ucns 2 and 3. A major binding domain of the CRFRs is the N terminus-first extracellular domain (ECD1). Soluble proteins corresponding to the ECD1s of each receptor bind CRF ligands with nanomolar affinities. Our three-dimentional (3D) nuclear magnetic resonance (NMR) structure of a soluble protein corresponding to the ECD1 of CRF-R2b (1) identified its structural fold as a Sushi domain-short consensus repeat (SCR), stabilized by three disulfide bridges, two tryptophan residues, and an internal salt bridge (Asp65-Arg101). Disruption of the bridge by D65A mutation abrogates ligand recognition and results in loss of the well-defined disulfide pattern and Sushi domain structure. NMR analysis of the ECD1 in complex with astressin identified key amino acids involved in ligand recognition. Mutation of some of these residues in the full-length receptor reduces its affinity for CRF ligands. A structure-based sequence comparison shows conservation of key amino acids in all the B1 subfamily receptors, suggesting a corresponding conservation of a Sushi domain structural fold of their ECD1s.
The corticotropin-releasing factor (CRF) receptors, CRF-R1 and CRF-R2, belong to the B1 subfamily of G protein-coupled Receptors (GPCRs), including receptors for secretin, growth hormone-releasing hormone (GHRH), vasoactive intestinal peptide (VIP), pituitary adenylate cyclase-activating polypeptide (PACAP), calcitonin, parathyroid hormone (PTH), glucagon, and glucagon-like peptide-1 (GLP-1). The peptide ligand family comprises CRF, Ucn 1, 2, and 3. CRF plays the major role in integrating the response to stress. Additionally, the ligands exhibit many effects on muscle, pancreas, heart, and the GI, reproductive, and immune systems. CRF-R1 has higher affinity for CRF than does CRF-R2 while both receptors bind Ucn 1 equally. CRF-R2 shows specificity for Ucns 2 and 3. A major binding domain of the CRFRs is the N terminus/first extracellular domain (ECD1). Soluble proteins corresponding to the ECD1s of each receptor bind CRF ligands with nanomolar affinities. Our three-dimensional (3D) nuclear magnetic resonance (NMR) structure of a soluble protein corresponding to the ECD1 of CRF-R2beta (1) identified its structural fold as a Sushi domain/short consensus repeat (SCR), stabilized by three disulfide bridges, two tryptophan residues, and an internal salt bridge (Asp65-Arg101). Disruption of the bridge by D65A mutation abrogates ligand recognition and results in loss of the well-defined disulfide pattern and Sushi domain structure. NMR analysis of the ECD1 in complex with astressin identified key amino acids involved in ligand recognition. Mutation of some of these residues in the full-length receptor reduces its affinity for CRF ligands. A structure-based sequence comparison shows conservation of key amino acids in all the B1 subfamily receptors, suggesting a corresponding conservation of a Sushi domain structural fold of their ECD1s.
The corticotropin-releasing factor (CRF) receptors, CRF-R1 and CRF-R2, belong to the B1 subfamily of G protein-coupled Receptors (GPCRs), including receptors for secretin, growth hormone-releasing hormone (GHRH), vasoactive intestinal peptide (VIP), pituitary adenylate cyclase-activating polypeptide (PACAP), calcitonin, parathyroid hormone (PTH), glucagon, and glucagon-like peptide-1 (GLP-1). The peptide ligand family comprises CRF, Ucn 1, 2, and 3. CRF plays the major role in integrating the response to stress. Additionally, the ligands exhibit many effects on muscle, pancreas, heart, and the GI, reproductive, and immune systems. CRF-R1 has higher affinity for CRF than does CRF-R2 while both receptors bind Ucn 1 equally. CRF-R2 shows specificity for Ucns 2 and 3. A major binding domain of the CRFRs is the N terminus/first extracellular domain (ECD1). Soluble proteins corresponding to the ECD1s of each receptor bind CRF ligands with nanomolar affinities. Our three-dimensional (3D) nuclear magnetic resonance (NMR) structure of a soluble protein corresponding to the ECD1 of CRF-R2beta (1) identified its structural fold as a Sushi domain/short consensus repeat (SCR), stabilized by three disulfide bridges, two tryptophan residues, and an internal salt bridge (Asp65-Arg101). Disruption of the bridge by D65A mutation abrogates ligand recognition and results in loss of the well-defined disulfide pattern and Sushi domain structure. NMR analysis of the ECD1 in complex with astressin identified key amino acids involved in ligand recognition. Mutation of some of these residues in the full-length receptor reduces its affinity for CRF ligands. A structure-based sequence comparison shows conservation of key amino acids in all the B1 subfamily receptors, suggesting a corresponding conservation of a Sushi domain structural fold of their ECD1s.The corticotropin-releasing factor (CRF) receptors, CRF-R1 and CRF-R2, belong to the B1 subfamily of G protein-coupled Receptors (GPCRs), including receptors for secretin, growth hormone-releasing hormone (GHRH), vasoactive intestinal peptide (VIP), pituitary adenylate cyclase-activating polypeptide (PACAP), calcitonin, parathyroid hormone (PTH), glucagon, and glucagon-like peptide-1 (GLP-1). The peptide ligand family comprises CRF, Ucn 1, 2, and 3. CRF plays the major role in integrating the response to stress. Additionally, the ligands exhibit many effects on muscle, pancreas, heart, and the GI, reproductive, and immune systems. CRF-R1 has higher affinity for CRF than does CRF-R2 while both receptors bind Ucn 1 equally. CRF-R2 shows specificity for Ucns 2 and 3. A major binding domain of the CRFRs is the N terminus/first extracellular domain (ECD1). Soluble proteins corresponding to the ECD1s of each receptor bind CRF ligands with nanomolar affinities. Our three-dimensional (3D) nuclear magnetic resonance (NMR) structure of a soluble protein corresponding to the ECD1 of CRF-R2beta (1) identified its structural fold as a Sushi domain/short consensus repeat (SCR), stabilized by three disulfide bridges, two tryptophan residues, and an internal salt bridge (Asp65-Arg101). Disruption of the bridge by D65A mutation abrogates ligand recognition and results in loss of the well-defined disulfide pattern and Sushi domain structure. NMR analysis of the ECD1 in complex with astressin identified key amino acids involved in ligand recognition. Mutation of some of these residues in the full-length receptor reduces its affinity for CRF ligands. A structure-based sequence comparison shows conservation of key amino acids in all the B1 subfamily receptors, suggesting a corresponding conservation of a Sushi domain structural fold of their ECD1s.
Author RIEK, ROLAND
GRACE, CHRISTY R. R.
VALE, WYLIE W.
PERRIN, MARILYN H.
Author_xml – sequence: 1
  givenname: MARILYN H.
  surname: PERRIN
  fullname: PERRIN, MARILYN H.
– sequence: 2
  givenname: CHRISTY R. R.
  surname: GRACE
  fullname: GRACE, CHRISTY R. R.
– sequence: 3
  givenname: ROLAND
  surname: RIEK
  fullname: RIEK, ROLAND
– sequence: 4
  givenname: WYLIE W.
  surname: VALE
  fullname: VALE, WYLIE W.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16888152$$D View this record in MEDLINE/PubMed
BookMark eNqNkU1LXDEUhkOx1PFj7U7uqrs75uPmaylj1YJY0HF9ycSTGrk3mSa5i-76E_ob_SVmGItQEF2dwHnel0OePbQTYgCEjgieE6LFiQnBDHlOGJFzLPgnNCOy060QjO6gGcZStkpTtov2cn7EmFDVyS9olwilFOF0hh6XD9AsHxLA05-_Z36EkH2snc1tSZMtU4ImuqZU6LoCS0ij32zP4mh82KwWMRVvY0lx7UNFbmAAk3342ZwbW2JqbsDCuj7yAfrs6rFw-DL30d35t-Xisr36cfF9cXrVWsZlaTkH7e6JoYRLQRzmTjhlVoKZleowc53ujGXAuNMdp0aAcAYktYZKqrRSbB993fauU_w1QS796LOFYTAB4pR7oSShtfpdkGgmtOq6D4GcKF7B4xdwWo1w36-TH0363f_77wqcbAGbYs4J3CuC-43Rfmu03xjtq9Ga4P8lrC-mVEklGT-8mXsGbq-qIA
CitedBy_id crossref_primary_10_1007_s00441_012_1450_4
crossref_primary_10_1016_j_ejphar_2010_01_027
crossref_primary_10_1007_s42000_018_0009_5
crossref_primary_10_1016_j_aanat_2016_05_004
crossref_primary_10_1146_annurev_pharmtox_48_113006_094630
crossref_primary_10_1002_ajmg_b_32046
crossref_primary_10_1016_j_ejphar_2024_176754
crossref_primary_10_1074_jbc_M806351200
crossref_primary_10_1523_JNEUROSCI_3172_09_2010
crossref_primary_10_1111_ahe_12094
crossref_primary_10_1021_jm300864p
crossref_primary_10_1111_ahe_12110
crossref_primary_10_1016_j_intimp_2021_107872
crossref_primary_10_1111_j_1365_2982_2009_01412_x
crossref_primary_10_1111_rda_13443
crossref_primary_10_1016_j_peptides_2010_01_004
crossref_primary_10_1152_physrev_00042_2017
crossref_primary_10_1124_pr_114_009464
crossref_primary_10_1155_2012_470851
crossref_primary_10_1177_1559325819860018
crossref_primary_10_6061_clinics_2017_09_09
crossref_primary_10_1016_j_repbio_2014_01_007
crossref_primary_10_1007_s00429_024_02879_0
crossref_primary_10_1002_ajmg_b_32115
crossref_primary_10_1210_er_2012_1092
crossref_primary_10_1124_mol_110_065474
crossref_primary_10_1002_cne_21848
crossref_primary_10_1002_jcp_21632
crossref_primary_10_1016_j_ygcen_2011_04_004
crossref_primary_10_1021_jm300259r
crossref_primary_10_1016_j_bmcl_2011_02_086
crossref_primary_10_1038_s41467_022_33851_3
Cites_doi 10.1073/pnas.92.7.2969
10.1074/jbc.M001596200
10.1074/jbc.M101770200
10.1124/mol.61.5.1132
10.1016/S0014-5793(96)01214-8
10.1073/pnas.92.4.1108
10.1093/intimm/12.4.439
10.1210/me.9.5.637
10.1016/S0301-4622(02)00005-4
10.1073/pnas.92.23.10575
10.1210/en.2002-0087
10.1111/j.1432-1033.2004.04216.x
10.1074/jbc.M406540200
10.1210/mend.11.13.0034
10.1038/364208a0
10.1074/jbc.273.9.4990
10.1073/pnas.0409583102
10.1093/emboj/18.22.6228
10.1046/j.1471-4159.1999.0720388.x
10.1073/pnas.051626398
10.1126/science.6267699
10.1038/87936
10.1073/pnas.90.19.8967
10.1046/j.1432-1327.1999.00007.x
10.1073/pnas.121165198
10.1074/jbc.M101838200
10.1073/pnas.0307200101
10.1021/jm034180
10.1146/annurev.pharmtox.44.101802.121410
10.1016/S0014-2999(99)00915-2
10.1016/S0028-3908(98)00201-9
10.1021/bi0001426
10.1046/j.1471-4159.1999.0730821.x
10.1210/me.12.8.1077
10.1016/S0196-9781(99)00122-9
10.1074/jbc.275.12.8508
10.1073/pnas.0404702101
10.1016/0896-6273(93)90230-O
10.1016/0014-5793(93)80427-V
10.1017/S0033583500005783
10.1038/nrm1130
10.1016/j.bbrc.2004.05.103
10.1084/jem.184.3.1185
10.1124/pr.55.1.3
10.1073/pnas.92.3.836
10.1073/pnas.97.18.10277
10.1038/349423a0
10.1016/S1359-6446(05)03370-2
10.1110/ps.12101
10.1021/bi036110a
10.1016/S0028-3908(00)00105-2
10.1002/cbic.200300769
10.1038/378287a0
10.1074/jbc.M210476200
10.1210/endo.139.2.5757
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7ST
7U6
C1K
7X8
DOI 10.1196/annals.1317.065
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Environment Abstracts
Sustainability Science Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Environment Abstracts
Sustainability Science Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList CrossRef
Environment Abstracts
Environment Abstracts
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Biology
EISSN 1749-6632
EndPage 119
ExternalDocumentID 16888152
10_1196_annals_1317_065
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIDDK NIH HHS
  grantid: P01 DK26741
GroupedDBID ---
--Z
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1CY
1OB
1OC
23M
31~
33P
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
692
6J9
702
79B
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AAHQN
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAYXX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABLJU
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACIWK
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADXHL
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AELAQ
AENEX
AEQDE
AEUYR
AEYWJ
AFBPY
AFFNX
AFFPM
AFGKR
AFRAH
AFSWV
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGYGG
AHBTC
AHDLI
AHEFC
AHMBA
AI.
AIAGR
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AUFTA
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BIYOS
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
C45
CAG
CITATION
CO8
COF
CS3
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRSTM
EBD
EBS
EJD
EMOBN
ESX
F00
F01
F04
F5P
FEDTE
FZ0
G-S
G.N
GODZA
H.T
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
I-F
IH2
IX1
J0M
K48
L7B
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NHB
O66
O9-
OHT
OIG
OK1
OVD
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RAG
RIWAO
RJQFR
ROL
RX1
S10
SAMSI
SJN
SUPJJ
SV3
TEORI
TUS
UB1
UPT
V8K
VH1
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIK
WOHZO
WQJ
WVDHM
WXSBR
X7M
XG1
YBU
YOC
YSK
ZGI
ZKB
ZXP
ZZTAW
~02
~IA
~KM
~WT
AAMDK
AEUQT
AFPWT
CGR
CUY
CVF
ECM
EIF
NPM
WRC
WUP
7ST
7U6
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
C1K
7X8
ID FETCH-LOGICAL-c357t-55e9fd1a215761f05f6f8ab63ab8403f494ac3e35f9452a6e6fae72ca27289883
ISSN 0077-8923
IngestDate Fri Jul 11 12:13:02 EDT 2025
Fri Jul 11 07:52:17 EDT 2025
Fri Jul 11 11:43:32 EDT 2025
Wed Feb 19 01:52:59 EST 2025
Tue Jul 01 01:28:51 EDT 2025
Thu Apr 24 23:02:59 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c357t-55e9fd1a215761f05f6f8ab63ab8403f494ac3e35f9452a6e6fae72ca27289883
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 16888152
PQID 19365185
PQPubID 23462
PageCount 15
ParticipantIDs proquest_miscellaneous_68712761
proquest_miscellaneous_19369844
proquest_miscellaneous_19365185
pubmed_primary_16888152
crossref_primary_10_1196_annals_1317_065
crossref_citationtrail_10_1196_annals_1317_065
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2006-Jul
PublicationDateYYYYMMDD 2006-07-01
PublicationDate_xml – month: 07
  year: 2006
  text: 2006-Jul
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Annals of the New York Academy of Sciences
PublicationTitleAlternate Ann N Y Acad Sci
PublicationYear 2006
References e_1_2_4_40_2
Liaw C.W. (e_1_2_4_30_2) 1997; 11
e_1_2_4_44_2
e_1_2_4_21_2
e_1_2_4_42_2
e_1_2_4_23_2
e_1_2_4_48_2
e_1_2_4_25_2
e_1_2_4_46_2
e_1_2_4_27_2
e_1_2_4_29_2
e_1_2_4_3_2
Perrin M.H. (e_1_2_4_35_2) 1998; 139
e_1_2_4_5_2
e_1_2_4_7_2
e_1_2_4_50_2
e_1_2_4_9_2
e_1_2_4_31_2
e_1_2_4_54_2
e_1_2_4_10_2
e_1_2_4_33_2
e_1_2_4_52_2
e_1_2_4_12_2
e_1_2_4_14_2
e_1_2_4_37_2
e_1_2_4_56_2
e_1_2_4_39_2
e_1_2_4_16_2
e_1_2_4_18_2
e_1_2_4_20_2
e_1_2_4_43_2
e_1_2_4_22_2
e_1_2_4_41_2
e_1_2_4_24_2
e_1_2_4_47_2
e_1_2_4_26_2
e_1_2_4_45_2
e_1_2_4_28_2
e_1_2_4_49_2
e_1_2_4_2_2
e_1_2_4_4_2
e_1_2_4_6_2
e_1_2_4_8_2
e_1_2_4_51_2
e_1_2_4_55_2
e_1_2_4_11_2
e_1_2_4_32_2
e_1_2_4_53_2
e_1_2_4_13_2
e_1_2_4_34_2
e_1_2_4_15_2
e_1_2_4_36_2
e_1_2_4_17_2
e_1_2_4_38_2
e_1_2_4_19_2
References_xml – ident: e_1_2_4_11_2
  doi: 10.1073/pnas.92.7.2969
– ident: e_1_2_4_28_2
  doi: 10.1074/jbc.M001596200
– ident: e_1_2_4_52_2
  doi: 10.1074/jbc.M101770200
– ident: e_1_2_4_33_2
  doi: 10.1124/mol.61.5.1132
– ident: e_1_2_4_42_2
  doi: 10.1016/S0014-5793(96)01214-8
– ident: e_1_2_4_12_2
  doi: 10.1073/pnas.92.4.1108
– ident: e_1_2_4_53_2
  doi: 10.1093/intimm/12.4.439
– ident: e_1_2_4_13_2
  doi: 10.1210/me.9.5.637
– ident: e_1_2_4_29_2
  doi: 10.1016/S0301-4622(02)00005-4
– ident: e_1_2_4_23_2
  doi: 10.1073/pnas.92.23.10575
– ident: e_1_2_4_22_2
  doi: 10.1210/en.2002-0087
– ident: e_1_2_4_14_2
  doi: 10.1111/j.1432-1033.2004.04216.x
– ident: e_1_2_4_55_2
  doi: 10.1074/jbc.M406540200
– volume: 11
  start-page: 2048
  year: 1997
  ident: e_1_2_4_30_2
  publication-title: Mol. Endocrinol.
  doi: 10.1210/mend.11.13.0034
– ident: e_1_2_4_47_2
  doi: 10.1038/364208a0
– ident: e_1_2_4_50_2
  doi: 10.1074/jbc.273.9.4990
– ident: e_1_2_4_18_2
  doi: 10.1073/pnas.0409583102
– ident: e_1_2_4_46_2
  doi: 10.1093/emboj/18.22.6228
– ident: e_1_2_4_37_2
  doi: 10.1046/j.1471-4159.1999.0720388.x
– ident: e_1_2_4_4_2
  doi: 10.1073/pnas.051626398
– ident: e_1_2_4_2_2
  doi: 10.1126/science.6267699
– ident: e_1_2_4_6_2
  doi: 10.1038/87936
– ident: e_1_2_4_7_2
  doi: 10.1073/pnas.90.19.8967
– ident: e_1_2_4_32_2
  doi: 10.1046/j.1432-1327.1999.00007.x
– ident: e_1_2_4_5_2
  doi: 10.1073/pnas.121165198
– ident: e_1_2_4_38_2
  doi: 10.1074/jbc.M101838200
– ident: e_1_2_4_54_2
  doi: 10.1073/pnas.0307200101
– ident: e_1_2_4_26_2
  doi: 10.1021/jm034180
– ident: e_1_2_4_20_2
  doi: 10.1146/annurev.pharmtox.44.101802.121410
– ident: e_1_2_4_34_2
  doi: 10.1016/S0014-2999(99)00915-2
– ident: e_1_2_4_15_2
  doi: 10.1016/S0028-3908(98)00201-9
– ident: e_1_2_4_41_2
  doi: 10.1021/bi0001426
– ident: e_1_2_4_31_2
  doi: 10.1046/j.1471-4159.1999.0730821.x
– ident: e_1_2_4_16_2
  doi: 10.1210/me.12.8.1077
– ident: e_1_2_4_49_2
  doi: 10.1016/S0196-9781(99)00122-9
– ident: e_1_2_4_21_2
  doi: 10.1074/jbc.275.12.8508
– ident: e_1_2_4_44_2
  doi: 10.1073/pnas.0404702101
– ident: e_1_2_4_9_2
  doi: 10.1016/0896-6273(93)90230-O
– ident: e_1_2_4_8_2
  doi: 10.1016/0014-5793(93)80427-V
– ident: e_1_2_4_45_2
  doi: 10.1017/S0033583500005783
– ident: e_1_2_4_56_2
  doi: 10.1038/nrm1130
– ident: e_1_2_4_48_2
  doi: 10.1016/j.bbrc.2004.05.103
– ident: e_1_2_4_51_2
  doi: 10.1084/jem.184.3.1185
– ident: e_1_2_4_19_2
  doi: 10.1124/pr.55.1.3
– ident: e_1_2_4_10_2
  doi: 10.1073/pnas.92.3.836
– ident: e_1_2_4_27_2
  doi: 10.1073/pnas.97.18.10277
– ident: e_1_2_4_17_2
  doi: 10.1038/349423a0
– ident: e_1_2_4_43_2
  doi: 10.1016/S1359-6446(05)03370-2
– ident: e_1_2_4_39_2
  doi: 10.1110/ps.12101
– ident: e_1_2_4_36_2
  doi: 10.1021/bi036110a
– ident: e_1_2_4_24_2
  doi: 10.1016/S0028-3908(00)00105-2
– ident: e_1_2_4_25_2
  doi: 10.1002/cbic.200300769
– ident: e_1_2_4_3_2
  doi: 10.1038/378287a0
– ident: e_1_2_4_40_2
  doi: 10.1074/jbc.M210476200
– volume: 139
  start-page: 566
  year: 1998
  ident: e_1_2_4_35_2
  publication-title: Endocrinology
  doi: 10.1210/endo.139.2.5757
SSID ssj0012847
Score 2.0478585
Snippet The corticotropin‐releasing factor (CRF) receptors, CRF‐R1 and CRF‐R2, belong to the B1 subfamily of G protein–coupled Receptors (GPCRs), including receptors...
The corticotropin-releasing factor (CRF) receptors, CRF-R1 and CRF-R2, belong to the B1 subfamily of G protein-coupled Receptors (GPCRs), including receptors...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 105
SubjectTerms Animals
Humans
Ligands
Models, Molecular
Mutation - genetics
Protein Conformation
Receptors, Corticotropin-Releasing Hormone - chemistry
Receptors, Corticotropin-Releasing Hormone - classification
Receptors, Corticotropin-Releasing Hormone - genetics
Receptors, Corticotropin-Releasing Hormone - metabolism
Subtitle Sushi Domains and the B1 Family of G Protein–Coupled Receptors
Title The Three‐Dimensional Structure of the N‐Terminal Domain of Corticotropin‐Releasing Factor Receptors
URI https://www.ncbi.nlm.nih.gov/pubmed/16888152
https://www.proquest.com/docview/19365185
https://www.proquest.com/docview/19369844
https://www.proquest.com/docview/68712761
Volume 1070
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswECXcFAV6KZp0c1ceekhhyNVCSmRvSZE4KBIXCGzUN4GSSNSoKxleDu639NgP7XCR5KRxt4tgSORYxnsmh-TMG4ReZzSnLFHEE0WWeUQm3OOwsvAKneBTEEXyWGcjXwzjszH5MKGTTuf7VtTSepX182835pX8D6pwD3DVWbL_gGxjFG7AZ8AXroAwXP8a4xWAIb1Ci_RbgY2elYTVBwPu_H_ouZCXWa-ovoppaWPJtb1qtdAZU54unSLMtoEtwNODgVDOdSUevWWwXC8_T13fZRNzeRzU2yNgbtAzig9gKq_W85ksWgvb_m-r11wHVxrNqKM2r8UNNst2zF4srM7BBSzrZ5uyTacYLNwRgFVIgNVEG_54OZVfbOS4q1HiyorZ6OlPG3C9bWzh9pZHUm95uGE8gamV20TlZhj3bQUSNxIHJpv7hhmCO2lk-LX9ALynvm-LVVzV4h5-TE_H5-fp6GQyuoVuhwl4ZtrlvmzEyczEbuZ59zJOOAq-4O0181d9nh0LGePQjO6je24lgo8srfZRR5YH6I6tTbo5QPs1EPjQSZO_eYB-AOPwL4zDDeNwpeCxxC3jsGWNfrCDcdgyDjd8eYcN31zPJQb8jNHjAFu-aWMDfI1vbf-HaHx6Mnp_5rk6H14e0WTlUSq5KgIB3mcSB8qnKlZMZHEkMkb8SBFORB7JiCpOaChiGSshkzAXYRIyzlj0CO2VVSmfIOwnUtBAiEj6jFChBLQIAy2BJMMoj0UX9Wsk0tyJ4OtaLLPULIa5SdAH6FINXQrQddFh02Fu9V92N31VQ5vCGK0P3kQpqzW04FFMwTH-fQvOCNndImZJACwMuuixZU37OjFjDNzwp3_s-wzdbf9Oz9EekEO-AJ96lb001P4J2lHWgQ
linkProvider Wiley-Blackwell
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+three-dimensional+structure+of+the+N-terminal+domain+of+corticotropin-releasing+factor+receptors%3A+sushi+domains+and+the+B1+family+of+G+protein-coupled+receptors&rft.jtitle=Annals+of+the+New+York+Academy+of+Sciences&rft.au=Perrin%2C+Marilyn+H&rft.au=Grace%2C+Christy+R+R&rft.au=Riek%2C+Roland&rft.au=Vale%2C+Wylie+W&rft.date=2006-07-01&rft.issn=0077-8923&rft.volume=1070&rft.spage=105&rft_id=info:doi/10.1196%2Fannals.1317.065&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0077-8923&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0077-8923&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0077-8923&client=summon